Ardent Health, Inc. (ARDT) shareholders
Close on Nov 17, 2026Market cap $2.50BP/E 32.3Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Chai Trust Company, LLC Joint filing with EGI-AM Investments, L.L.C. (54.10%), EGI-AM Investor, L.L.C. (54.10%) | 77,246,499 | 54.10% | 13G (passive) | Sep 30, 2024 |
| Pure Health Capital Americas 1 SPV RSC LTD (1) Joint filing with Pure Health Holding PJSC (1) (21.20%), Pure Health Medical Supplies LLC (1) (21.20%) and 1 more | 30,262,664 | 21.20% | 13G (passive) | Sep 30, 2024 |
| Ventas, Inc. | 9,342,501 | 6.55% | 13G (passive) | Jul 17, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ARDT | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Chai Trust Co LLC | 77,246,499 | 54.77% | $760.11M | – | 52.26% |
| Ventas, Inc. | 9,342,501 | 6.62% | $91.93M | – | 100.00% |
| BlackRock, Inc. | 2,176,348 | 1.54% | $21.42M | +418,133 | 0.00% |
| Ameriprise Financial Inc | 2,110,599 | 1.50% | $20.77M | +333,873 | 0.00% |
| Goldentree Asset Management LP | 1,580,423 | 1.12% | $15.53M | −722,690 | 0.90% |
| Aqr Capital Management LLC | 1,447,810 | 1.03% | $14.25M | +505,457 | 0.00% |
| CastleKnight Management LP | 1,076,967 | 0.76% | $10.60M | – | 0.14% |
| Vanguard Capital Management LLC | 963,833 | 0.68% | $9.48M | −44,605 | 0.00% |
| Bridgeway Capital Management, LLC | 841,126 | 0.60% | $8.28M | −89,542 | 0.15% |
| Geode Capital Management, LLC | 620,947 | 0.44% | $6.11M | +59,504 | 0.00% |
| Algert Global LLC | 597,745 | 0.42% | $5.88M | +554,345 | 0.07% |
| State Street Corp | 566,205 | 0.40% | $5.57M | −19,853 | 0.00% |
| First Trust Advisors LP | 562,278 | 0.40% | $5.53M | +83,483 | 0.00% |
| Empowered Funds, LLC | 551,293 | 0.39% | $5.42M | +15,458 | 0.03% |
| SageView Advisory Group, LLC | 480,447 | 0.34% | $4.73M | −160,149 | 0.15% |
| Hotchkis & Wiley Capital Management LLC | 444,896 | 0.32% | $4.38M | +2,300 | 0.01% |
| UBS Group AG | 442,619 | 0.31% | $4.36M | −8,061 | 0.00% |
| Bank Of America Corp /De/ | 390,241 | 0.28% | $3.84M | +29,203 | 0.00% |
| Wedge Capital Management L L P/Nc | 327,242 | 0.23% | $3.22M | +222,447 | 0.05% |
| Morgan Stanley | 315,960 | 0.22% | $3.11M | +23,929 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 139 | 108M | 76.9% | 23 / 67 | 35 / 19 | 4M | 3M |
| Q1 2026 | 137 | 107M | 75.8% | 32 / 50 | 37 / 19 | 5M | 3M |
| Q4 2025 | 127 | 107M | 75.5% | 34 / 37 | 44 / 30 | 5M | 5M |
| Q3 2025 | 123 | 107M | 75.8% | 36 / 53 | 25 / 23 | 14M | 3M |
| Q2 2025 | 110 | 95M | 67.4% | 21 / 48 | 31 / 19 | 3M | 3M |
| Q1 2025 | 108 | 94M | 67.0% | 39 / 44 | 19 / 18 | 7M | 5M |
| Q4 2024 | 89 | 103M | 72.9% | 28 / 33 | 15 / 12 | 12M | 2M |
| Q3 2024 | 73 | 93M | 65.8% | 73 / 0 | 0 / 0 | 93M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
134 funds held ARDT in Q2 2026, 52% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of ARDT | Value | % of fund | As of |
|---|---|---|---|---|---|
| Columbia Small Cap Value Discovery Fund | 1,028,221 | 0.73% | $10.97M | 0.44% | Jul 31, 2026 |
| Vanguard Total Stock Market Index Fund | 661,990 | 0.47% | $6.51M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 644,482 | 0.46% | $6.34M | 0.01% | Jun 30, 2026 |
| EA Bridgeway Omni Small-Cap Value ETF | 551,293 | 0.39% | $5.42M | 0.23% | Jun 30, 2026 |
| Columbia Small Cap Value and Inflection Fund | 452,380 | 0.32% | $4.18M | 0.48% | May 31, 2026 |
| First Trust Small Cap Core AlphaDEX Fund | 443,260 | 0.31% | $4.73M | 0.35% | Jul 31, 2026 |
| Omni Small-Cap Value Fund | 289,833 | 0.21% | $2.85M | 0.22% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 271,704 | 0.19% | $2.67M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 259,189 | 0.18% | $2.77M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 230,800 | 0.16% | $2.27M | 0.02% | Jun 30, 2026 |
| Columbia Variable Portfolio - Small Cap Value Discovery Fund | 185,951 | 0.13% | $1.83M | 0.41% | Jun 30, 2026 |
| WisdomTree U.S. SmallCap Fund | 170,484 | 0.12% | $1.68M | 0.23% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 130,622 | 0.09% | $1.21M | 0.00% | May 31, 2026 |
| Hotchkis and Wiley Small Cap Diversified Value Fund | 124,000 | 0.09% | $1.22M | 0.13% | Jun 30, 2026 |
| First Trust Small Cap Value AlphaDEX Fund | 121,445 | 0.09% | $1.30M | 0.67% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Dave Caspers | CEO and President, Director | 174,930 | 0.12% | Jul 2, 2026 |
| Martin Bonick | President and CEO, Director | 1,437,937 | 1.02% | Apr 2, 2026 |
| Stephen C. Petrovich | EVP, GC and Secretary | 960,144 | 0.68% | Sep 29, 2026 |
| David Raynor Byers | SVP & Chief Accounting Officer | 129,921 | 0.09% | Sep 29, 2026 |
| Alfred Lumsdaine | Chief Financial Officer | 325,794 | 0.23% | Sep 29, 2026 |
| Ethan Chernin | President of Health Services | 68,396 | 0.05% | Mar 13, 2026 |
| David Schultz | President Hospital Operations | 64,172 | 0.05% | Apr 2, 2025 |
| Robert DeMichiei | Director | 35,564 | 0.03% | Jun 8, 2026 |
| Peter J. Bulgarelli | Director | 14,231 | 0.01% | Apr 2, 2026 |
| Robert Thomas Webb | Director | 78,215 | 0.06% | Apr 2, 2026 |
| Peter C. B. Bynoe | Director | 115,367 | 0.08% | Apr 2, 2026 |
| Rahul Sen | Director | 38,709 | 0.03% | Apr 2, 2026 |
| Suzanne Campion | Director | 58,215 | 0.04% | Apr 2, 2026 |
| Edmondo Robinson | Director | 58,215 | 0.04% | Apr 2, 2026 |
| Ellen Havdala | Director | 115,367 | 0.08% | Apr 2, 2026 |
| Mark R. Sotir | Director | 38,709 | 0.03% | Apr 2, 2026 |
| William M. Goodyear | Director | 115,367 | 0.08% | Apr 2, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Stephen C. Petrovich EVP, GC and Secretary | Sep 25, 2026 | Tax withholding | −788 | $10.54 | $8.31K | 773,919 |
| Alfred Lumsdaine Chief Financial Officer | Sep 25, 2026 | Tax withholding | −3,389 | $10.54 | $35.72K | 325,794 |
| David Raynor Byers SVP & Chief Accounting Officer | Sep 25, 2026 | Tax withholding | −524 | $10.54 | $5.52K | 129,921 |
| Dave Caspers CEO and President, Director | Jul 1, 2026 | Award | +103,653 | – | – | 174,930 |
| Robert DeMichiei Director | Jun 5, 2026 | Buy | +11,260 | $8.73 | $98.30K | 35,564 |
| Alfred Lumsdaine Chief Financial Officer | Jun 5, 2026 | Buy | +10,000 | $8.81 | $88.10K | 329,183 |
| Peter J. Bulgarelli Director | Apr 1, 2026 | Award | +14,231 | – | – | 14,231 |
| Rahul Sen Director | Apr 1, 2026 | Award | +14,231 | – | – | 38,709 |
| Martin Bonick President and CEO, Director | Apr 1, 2026 | Award | +134,615 | – | – | 1,437,937 |
| Martin Bonick President and CEO, Director | Apr 1, 2026 | Tax withholding | −10,952 | $8.67 | $94.95K | 1,303,322 |
| David Raynor Byers SVP & Chief Accounting Officer | Apr 1, 2026 | Award | +11,538 | – | – | 130,445 |
| David Raynor Byers SVP & Chief Accounting Officer | Apr 1, 2026 | Tax withholding | −924 | $8.67 | $8.01K | 118,907 |
| Edmondo Robinson Director | Apr 1, 2026 | Award | +14,231 | – | – | 58,215 |
| William M. Goodyear Director | Apr 1, 2026 | Award | +14,231 | – | – | 115,367 |
| Dave Caspers Chief Operating Officer | Apr 1, 2026 | Award | +35,673 | – | – | 71,277 |
| Dave Caspers Chief Operating Officer | Apr 1, 2026 | Tax withholding | −2,684 | $8.67 | $23.27K | 35,604 |
| Stephen C. Petrovich EVP, GC and Secretary | Apr 1, 2026 | Tax withholding | −1,808 | $8.67 | $15.68K | 749,803 |
| Stephen C. Petrovich EVP, GC and Secretary | Apr 1, 2026 | Award | +24,904 | – | – | 774,707 |
| Mark R. Sotir Director | Apr 1, 2026 | Award | +14,231 | – | – | 38,709 |
| Peter C. B. Bynoe Director | Apr 1, 2026 | Award | +14,231 | – | – | 115,367 |
| Suzanne Campion Director | Apr 1, 2026 | Award | +14,231 | – | – | 58,215 |
| Robert DeMichiei Director | Apr 1, 2026 | Award | +14,231 | – | – | 24,304 |
| Ellen Havdala Director | Apr 1, 2026 | Award | +14,231 | – | – | 115,367 |
| Robert Thomas Webb Director | Apr 1, 2026 | Award | +14,231 | – | – | 78,215 |
| Alfred Lumsdaine Chief Financial Officer | Apr 1, 2026 | Award | +53,846 | – | – | 319,183 |
| Alfred Lumsdaine Chief Financial Officer | Apr 1, 2026 | Tax withholding | −4,381 | $8.67 | $37.98K | 265,337 |
| Martin Bonick President and CEO, Director | Mar 31, 2026 | Tax withholding | −8,026 | $8.56 | $68.70K | 1,314,274 |
| David Raynor Byers SVP & Chief Accounting Officer | Mar 31, 2026 | Tax withholding | −819 | $8.56 | $7.01K | 119,831 |
| Stephen C. Petrovich EVP, GC and Secretary | Mar 31, 2026 | Tax withholding | −1,425 | $8.56 | $12.20K | 751,611 |
| Alfred Lumsdaine Chief Financial Officer | Mar 31, 2026 | Tax withholding | −2,510 | $8.56 | $21.49K | 269,718 |
| Alfred Lumsdaine Chief Financial Officer | Mar 11, 2026 | Award | +61,081 | – | – | 272,228 |
| Martin Bonick President and CEO, Director | Mar 11, 2026 | Award | +195,316 | – | – | 1,322,300 |
| Ethan Chernin President of Health Services | Mar 11, 2026 | Award | +32,408 | – | – | 68,396 |
| David Raynor Byers SVP & Chief Accounting Officer | Mar 11, 2026 | Award | +8,859 | – | – | 120,650 |
| Stephen C. Petrovich EVP, GC and Secretary | Mar 11, 2026 | Award | +34,733 | – | – | 753,036 |
| David Raynor Byers SVP & Chief Accounting Officer | Sep 25, 2025 | Tax withholding | −524 | $13.19 | $6.91K | 111,791 |
| Stephen C. Petrovich EVP, GC and Asst. Secretary | Sep 25, 2025 | Tax withholding | −788 | $13.19 | $10.39K | 718,303 |
| Alfred Lumsdaine Chief Financial Officer | Sep 25, 2025 | Tax withholding | −3,389 | $13.19 | $44.70K | 211,147 |
| Robert DeMichiei Director | Apr 2, 2025 | Award | +10,073 | – | – | 10,073 |
| Martin Bonick President and CEO, Director | Apr 1, 2025 | Award | +134,927 | – | – | 1,126,984 |
| Stephen C. Petrovich EVP, GC and Asst. Secretary | Apr 1, 2025 | Award | +22,263 | – | – | 719,091 |
| David Raynor Byers SVP & Chief Accounting Officer | Apr 1, 2025 | Award | +11,565 | – | – | 112,315 |
| Ethan Chernin President of Health Services | Apr 1, 2025 | Award | +20,914 | – | – | 35,988 |
| David Schultz President Hospital Operations | Apr 1, 2025 | Award | +26,985 | – | – | 64,172 |
| Dave Caspers Chief Operating Officer | Apr 1, 2025 | Award | +33,057 | – | – | 38,288 |
| Dave Caspers Chief Operating Officer | Apr 1, 2025 | Tax withholding | −2,480 | $12.97 | $32.17K | 5,231 |
| Dave Caspers Chief Operating Officer | Apr 1, 2025 | Award | +7,711 | – | – | 7,711 |
| Alfred Lumsdaine Chief Financial Officer | Apr 1, 2025 | Award | +53,971 | – | – | 214,536 |
| Martin Bonick President and CEO, Director | Mar 31, 2025 | Tax withholding | −12,970 | $13.75 | $178.34K | 992,057 |
| Stephen C. Petrovich EVP, GC and Asst. Secretary | Mar 31, 2025 | Tax withholding | −1,428 | $13.75 | $19.64K | 696,828 |
| David Raynor Byers SVP & Chief Accounting Officer | Mar 31, 2025 | Tax withholding | −676 | $13.75 | $9.30K | 100,750 |
| Ethan Chernin President of Health Services | Mar 31, 2025 | Tax withholding | −1,332 | $13.75 | $18.32K | 15,074 |
| David Schultz President Hospital Operations | Mar 31, 2025 | Tax withholding | −1,825 | $13.75 | $25.09K | 37,187 |
| Alfred Lumsdaine Chief Financial Officer | Mar 31, 2025 | Tax withholding | −2,510 | $13.75 | $34.51K | 160,565 |
| Peter C. B. Bynoe Director | Mar 21, 2025 | Award | +12,916 | – | – | 101,136 |
| William M. Goodyear Director | Mar 21, 2025 | Award | +12,916 | – | – | 101,136 |
| Edmondo Robinson Director | Mar 21, 2025 | Award | +12,916 | – | – | 43,984 |
| Rahul Sen Director | Mar 21, 2025 | Award | +12,916 | – | – | 24,478 |
| Suzanne Campion Director | Mar 21, 2025 | Award | +12,916 | – | – | 43,984 |
| Mark R. Sotir Director | Mar 21, 2025 | Award | +12,916 | – | – | 24,478 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Ardent Health's stock actually held short. Settlement fails (shares not delivered on time) peaked at 39,573 shares on Sep 16, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Martin Bonick Former Officer & Director | Aug 27, 2026 | 35,930 | $398.03K | Aug 27, 2026 | Restricted Stock Vesting |
| Martin Bonick Former Officer & Director | Aug 25, 2026 | 35,930 | $401.36K | Aug 25, 2026 | Restricted Stock Vesting |
| Martin Bonick Former Officer & Director | Aug 20, 2026 | 35,930 | $377.36K | Aug 20, 2026 | Restricted Stock Vesting |
| Martin Bonick Former Officer & Director | Aug 18, 2026 | 35,930 | $393.48K | Aug 18, 2026 | Restricted Stock Vesting |
See a number that looks wrong?